To investigate the clinical significance of NUCB2, we collected serum samples from 40 healthy donors and 40 breast cancer patients and measured the concentration of Nesfatin-1, a cleavage product of NUCB2 (Additional file 1: Fig. S1A), using ELISA. This evidence concerns the gene NUCB2 and breast cancer.